| 5HYS: reference: Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange., Pennington LF, Tarchevskaya S, Brigger D, Sathiyamoorthy K, Graham MT, Nadeau KC, Eggel A, Jardetzky TS, Nat Commun. 2016 May 19;7:11610. doi: 10.1038/ncomms11610. PMID: 27194387 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).